This Working Group aimed to document how CTSA Research Pharmacies contribute to the development of new drug products and dosage forms through translational research. By doing so, the group aimed to help physician scientists better understand how a research pharmacy can support translational research. This aimed to facilitate drug development pathways in the academic setting and encourage pharmacists to share formulation and regulatory expertise across institutions, improving local expertise for CTSA pharmacies. Additionally, the group worked to inform pharmacists on how to further contribute to CTSA research locally.
CTSA Pharmacies and Compounding for Translational Research
Overview
This Working Group aimed to document how CTSA Research Pharmacies contribute to the development of new drug products and dosage forms through translational research. By doing so, the group aimed to help physician scientists better understand how a research pharmacy can support translational research. This aimed to facilitate drug development pathways in the academic setting and encourage pharmacists to share formulation and regulatory expertise across institutions, improving local expertise for CTSA pharmacies. Additionally, the group worked to inform pharmacists on how to further contribute to CTSA research locally.
Group Goals
Identify drug products developed with CTSA research pharmacy compounding services using translational science.
Demonstrate how compounding of novel products for unmet medical needs preceded early clinical translational studies, patents, and approvals.
Show how research pharmacies supported early clinical translational studies of first-in-human products for new chemical entities, using FDA, Clinicaltrials.gov, PubMed, and PharmaProjects data.
Meeting Archive
This group met regularly to work towards achieving the goals of the CTSA Program. For questions, please contact support@ccos.ctsa.io.
